Standout Papers

Phase Ib Study of Lenvatinib Plus Pembrolizumab in Patients With Unresectable Hepatocellular Carcinoma 2020 2026 2022 2024818
  1. Phase Ib Study of Lenvatinib Plus Pembrolizumab in Patients With Unresectable Hepatocellular Carcinoma (2020)
    Richard S. Finn, Masafumi Ikeda et al. Journal of Clinical Oncology

Immediate Impact

5 by Nobel laureates 17 from Science/Nature 60 standout
Sub-graph 1 of 17

Citing Papers

Probiotic neoantigen delivery vectors for precision cancer immunotherapy
2024 StandoutNature
Tumour vasculature at single-cell resolution
2024 StandoutNature
3 intermediate papers

Works of Max W. Sung being referenced

The Novel Role of Tyrosine Kinase Inhibitor in the Reversal of Immune Suppression and Modulation of Tumor Microenvironment for Immune-Based Cancer Therapies
2009

Author Peers

Author Last Decade Papers Cites
Max W. Sung 1556 2128 814 870 81 3.9k
Mohamed Bouattour 1409 1831 692 552 103 3.1k
Su Pin Choo 1691 2241 793 633 135 4.2k
В. В. Бредер 1867 2364 827 499 100 3.7k
Sadahisa Ogasawara 1181 2793 1281 599 132 3.8k
Baogang Peng 1170 1654 855 793 102 3.5k
Matthias Pinter 1066 2815 1987 845 150 4.5k
Gerold Meinhardt 1277 2706 1019 500 57 4.7k
Min-Shan Chen 1364 3273 1910 1286 58 5.2k
Wolfgang Sieghart 977 2527 1776 797 86 4.6k
Abby B. Siegel 2230 3215 1488 1038 91 5.6k

All Works

Loading papers...

Rankless by CCL
2026